Found 40 matching trials
A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products
PHASE4This study is to see if there's any difference in the amount of facial irri...
Location
Skin Study Center
Clinical Evaluation of the Photoallergy Potential of Atralin Gel
PHASE1To assess the potential of tretinoin gel 0.05% and its vehicle to produce p...
Location
Suncare Research Laboratories
Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face
PHASE4A study to compare the skin irritation potential of two marketed gels for a...
Location
Skin Study Center
Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo
NAZIANA® (clindamycin phosphate 1.2% and tretinoin 0.025%) gel, marketed by M...
Location
Lotus Labs Pvt. Ltd
W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers
PHASE1Clindamycin 1.0% - tretinoin 0.025% gel (CT Gel) is a reformulation of VELA...
Location
Multiple Locations
A Study of Acne Treatment in Children Ages 9 to 11
PHASE2A study to determine if using Retin-A Micro 0.04% as facial acne treatment ...
Location
Encino Research Center
Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face
PHASE4A study to compare the skin irritation potential of two marketed gels for a...
Location
Skin Study Center
Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris
PHASE4The purpose of this research study is to evaluate the effectiveness of two ...
Location
Wake Forest University Health Sciences, Dermatology
Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris
PHASE4A 12-week evaluation of the safety and efficacy of dapsone gel 5% when used...
Location
Multiple Locations
A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma
NAThe purpose of this study is to see if ALRT1057 gel is safe and effective i...
Location
Multiple Locations